PrimeRFP SCOUT · Federal Contract Recompete Brief

75N95021P00564Nanosims analysis of mitochondrial metabolism in — Brigham and Women'S Hospital, Inc.., the

Brigham and Women'S Hospital, Inc.., the holds $20.7M across 79 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Sep 26, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

National Institutes Of Health Nida

Awarding office

Brigham and Women'S Hospital, Inc.., the

Recipient

Sep 26, 2025

PoP end

$99K

Obligated

$246K

Potential

541713

NAICS

6640

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Brigham and Women'S Hospital, Inc.., the — $90

Contract facts

NONE

Contract number75N95021P00564

AgencyNational Institutes Of Health Nida

Awarding officeNational Institutes Of Health Nida

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentBrigham and Women'S Hospital, Inc.., the

CAGE0W3J1

UEIQN6MS4VN7BD1

NAICS541713

No full NAICS 541713 intel page yet. Browse NAICS intelligence

PSC6640

Place of performanceBOSTON MA

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

Related solicitation75N95021Q00166

PoP startSep 27, 2021

PoP end (current)Sep 26, 2025

PoP end (w/ options)Sep 26, 2026

Obligated$99K

Current value$195K

Potential value$246K

NANOSIMS ANALYSIS OF MITOCHONDRIAL METABOLISM IN MOUSE MODELS OF NEURODEGENERATION. ESTIMATED OPTION ONE POP: 09/27/2022 - 09/26/2023. is a federal NONE award for National Institutes Of Health Nida held by Brigham and Women'S Hospital, Inc.., the. Estimated value $246K ($99K obligated). Current period of performance ends Sep 26, 2025 (potential Sep 26, 2026). Last award drew 1 bidder. Place of performance: BOSTON MA. Related solicitation 75N95021Q00166.

NANOSIMS ANALYSIS OF MITOCHONDRIAL METABOLISM IN MOUSE MODELS OF NEURODEGENERATION. ESTIMATED OPTION ONE POP: 09/27/2022 - 09/26/2023.

Recompete timing

Public

● Past PoP end (329 days ago)

Current PoP ended Sep 26, 2025 (329 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Brigham and Women'S Hospital, Inc.., the — $20.7M obligated across 79 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($20.7M) · all agencies

Department of Veterans Affairs (VA)$13.0M · 63%Department of Health and Human Services (HHS)$6.9M · 33%National Aeronautics and Space Administration (NASA)$1.5M · 7%Department of Justice (DOJ)$14K · 0%

Related awards

Same incumbent

36C24E25N0248

GGENOMIC MEDICINE RESEARCH

$229K

Sep 10, 2026

36C24E25N0234

BIOINFORMATICS RESEARCH SUPPORT

$559K

Sep 13, 2026

36C24E25N0231

BIOINFORMATICS RESEARCH SUPPORT - DIV OF AGING

$542K

Sep 13, 2026

36C24E25N0235

BIOINFORMATICS RESEARCH SUPPORT

$399K

Sep 13, 2026

36C24E25N0233

BIOINFORMATICS RESEARCH SUPPORT

$112K

Sep 13, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N95021P00564?

75N95021P00564 (Nanosims analysis of mitochondrial metabolism in) is a National Institutes Of Health Nida award with a potential value of $246K, currently held by Brigham and Women'S Hospital, Inc.., the. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N95021P00564?

National Institutes Of Health Nida awarded 75N95021P00564 to Brigham and Women'S Hospital, Inc.., the (potential $246K).

Who is the incumbent on 75N95021P00564?

Brigham and Women'S Hospital, Inc.., the is the incumbent with $20.7M across 79 related awards in SCOUT’s public footprint. The current period of performance ends Sep 26, 2025.

When does Brigham and Women'S Hospital, Inc.., the’s 75N95021P00564 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 26, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Aug 9, 2024